Birmingham, ALNCT07069673Now EnrollingIRB Ready

Mitral Regurgitation Clinical Trial in Birmingham, AL

Access cutting-edge mitral regurgitation treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.

Sponsored by Abbott Medical Devices

Quick Self-Assessment

See if you qualify for this Birmingham location

Preparing your pre-screening questions…

Expert Care in Birmingham

Access mitral regurgitation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mitral regurgitation treatment provided free

Apply for This Birmingham Location

Check if you qualify for this mitral regurgitation clinical trial in Birmingham, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Birmingham

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Birmingham site if eligible
  4. 4Begin participation

About This Mitral Regurgitation Study in Birmingham

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of correcting symptomatic mitral valve disease on clinical outcomes in patients that could be candidates for Transcatheter Mitral Valve Replacement and may also inform future regulatory or reimbursement submission strategies for the Cephea Mitral Valve System.

Sponsor: Abbott Medical Devices

Who Can Participate

Inclusion Criteria

Symptomatic mitral valve disease resulting in mitral regurgitation and/or severe mitral valve stenosis.
New York Heart Association (NYHA) Functional Class II, III, or ambulatory IV.
In the judgement of the Site Heart Team, transcatheter therapy is deemed to be more appropriate than conventional mitral valve surgery, TMVR is more likely to provide an optimal result than TEER, and the subject has been adequately treated per applicable standards, including for coronary artery disease, left ventricular dysfunction, and heart failure.
Age 18 years or older at time of consent.
The subject agrees to the study requirements, permits all follow-up data entry, and has provided written informed consent.

Exclusion Criteria

Prior surgical or interventional treatment that interferes with the Cephea valve delivery or function.
Subject is undergoing dialysis or experiencing chronic renal failure
Subject has chronic lung disease requiring continuous home oxygen therapy or chronic outpatient oral steroid use
Subjects with comorbidities that are likely to result in a life expectancy of less than 12 months.
Pregnant or nursing subjects and those who plan pregnancy during the follow-up period.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Birmingham?

Yes, this clinical trial (NCT07069673) has an active research site in Birmingham, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Mitral Regurgitation Treatment Options in Birmingham, AL

If you're searching for mitral regurgitation treatment options in Birmingham, AL, this clinical trial (NCT07069673) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mitral regurgitation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all mitral regurgitation clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Birmingham, AL

See all heart attack clinical trials recruiting in Birmingham — not just this study.

Browse Heart Attack Trials in Birmingham →

Browse More Trials by Condition

Heart Attack TrialsValvular Heart Disease TrialsRheumatoid Arthritis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Birmingham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Birmingham, AL